Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Fördersumme: € 999.285
Predicting the evolution of relapse in Wilms tumour using drug sensitivity profiling and liquid biopsies
Fördersumme: € 999.538
Personalized risk assessment for embryonal tumor predisposition
Fördersumme: € 999.003
Functional Identification of Response Biomarkers to Advance Precision Oncology in Childhood Cancers
Fördersumme: € 999.357
Uncovering the Genetic Contribution of Human Endogenous Retroviruses to ME/CFS
Fördersumme: € 39.504
Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Dauer: 48 Monate, Fördersumme: € 899.099